Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trialsFengcai Zhu, Ningshao Xia, Chunlan Zhuang et al.|The Lancet Respiratory Medicine|2022Cited by 140
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trialShoujie Huang, Ningshao Xia, Xiaohui Liu et al.|The Lancet|2024Cited by 70
The role of MAP2 kinases and p38 kinase in acute murine liver injury modelsJun Zhang, Neil Kaplowitz|Cell Death and Disease|2017Cited by 65
<p>KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer</p>Jun Zhang, Guowei Shi|OncoTargets and Therapy|2020Cited by 62
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYuemei Hu, Ningshao Xia, Zhaofeng Bi et al.|Science Bulletin|2023Cited by 26